Federal Trade Commission (FTC)

In a landmark decision, a federal court has unanimously upheld the lifetime ban preventing Martin Shkreli, infamously known as "Pharma Bro," from working in the pharmaceuticals industry. The court's ruling also includes a hefty financial penalty, requiring Shkreli to pay $64 million in profits for impeding competition to his HIV drug.

The controversial figure, once labeled the "most hated man in America," gained notoriety in 2015 when he shockingly raised the price of a life-saving HIV drug by over four-thousand-percent overnight. Shkreli's actions sparked widespread outrage and led to legal consequences, including a conviction for. . .